(Q40990155)

English

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin

scientific article published on January 1, 1979

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin (English)

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

author name string

R. H. Creech

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367574

9 April 2023

R. B. Catalano

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367574

9 April 2023

D. T. Harris

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367574

9 April 2023

P. F. Engstrom

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367574

9 April 2023

P. J. Grotzinger

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367574

9 April 2023

language of work or name

0 references

publication date

1 January 1979

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

51-59

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard

1

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast

2

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer

4

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer

5

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study

8

1 reference

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

https://api.crossref.org/works/10.1002/1097-0142(197901)43:1%3C51::AID-CNCR2820430107%3E3.0.CO;2-N

9 April 2023

Identifiers

10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40990155&oldid=2142723197"